reproductive

Question 1

BV

Answer 1

Bacterial vaginosis

Question 2

AMN

Answer 2

Amniocenteis

Question 3

L & D

Answer 3

Labor & Delivery

Question 4

HRT

Answer 4

Hormone replacement therapy

Question 5

HPV

Answer 5

Human papilloma virus

Question 6

IUD

Answer 6

Intrauterine device

Question 7

PID

Answer 7

Pelvic inflammatory disease

Question 8

Trich

Answer 8

Trichomoniasis

Question 9

Menarche

Answer 9

Beginning of menstrual function

Question 10

Menopause

Answer 10

Normal termination of menstrual function

Question 11

Perimenopause

Answer 11

Transition phase between regular menstrual periods and no periods at all

Question 12

Amenorrhea

Answer 12

Abnormal absence of menstrual periods for 3 or more months

Question 13

Dysmenorrhea

Answer 13

Pain caused by uterine cramps during menstrual period

Question 14

Estradiol

Answer 14

Estrogens

Question 15

Estradiol MOA

Answer 15

Developing & maintaining female reproductive system & secondary sex characteristics
Involved in shaping skeleton and inhibiting bone resorption

Question 16

Estradiol indications

Answer 16

Treatment of moderate to severe vasomotor symptoms

Prevention of osteoporosis

Question 17

Estradiol adverse effects

Answer 17

Vaginal bleeding, breast tenderness, nausea and vomiting

Question 18

Estradiol key facts

Answer 18

Contraindications: pregnancy, undiagnosed vaginal bleeding; known or suspected breast cancer, active thromboembolic disorder, severe liver disease

Question 19

Estradiol counseling

Answer 19

Increase risk of endometrial carcinoma in postmenopausal women
Women with uterus should also receive monthly progestins

Question 20

Medroxyprogesterone

Answer 20

Progestins

Question 21

Medroxyprogesterone MOA

Answer 21

Inhibit secretion of gonadtropins

Question 22

Medroxyprogesterone indications

Answer 22

Prevention of pregnancy

Abnormal uterine bleeding due to hormonal imbalance

Question 23

Medroxyprogesterone adverse effects

Answer 23

Breakthrough bleeding, nausea

Question 24

Depo-Provera injection key facts

Answer 24

May lose significant bone mineral density

Used as long term birth control method (> 2 years) only if other birth control methods are inadequate

Question 25

Medroxyprogesterone counseling

Answer 25

Progestin withdrawal bleeding occurs within 3 – 7 days after discontinuing oral therapy

Question 26

Depo-Provera counseling

Answer 26

At beginning of therapy, menstrual cycle may be disrupted and irregular and unpredictable bleeding or spotting may occur

Question 27

Norgestrel / ethinyl estradiol

Answer 27

Monophasic Oral Contraceptive

Question 28

Norgestrel / ethinyl estradiol MOA

Answer 28

Inhibit ovulation by suppressing gonadotropins , follicle stimulating hormone (FSH) and luteinizing hormone (LH).

Question 29

Norgestrel / ethinyl estradiol indication

Answer 29

Prevention of pregnancy in women, treatment of menorrhagia, pain associated with endometriosis, dysmenorrhea

Question 30

Norgestrel / ethinyl estradiol adverse effects

Answer 30

Nausea, vomiting, bloating, migraine headaches, edema, breast tenderness, breakthrough bleeding, change in menstrual flow, weight gain, tiredness, fatigue, depression

Question 31

Norgestrel / ethinyl estradiol key facts

Answer 31

Prescribed with caution if ever, to smokers, > 35 years of age Smokers < 30 years of age who are otherwise healthy generally can use combined oral contraceptives

Question 32

Norgestrel / ethinyl estradiol counseling

Answer 32

Take at same time each day Spotting or breakthrough bleeding during first few months of therapy Use additional method of birth control during first week of pills during initial cycle of OC pills Notify healthcare provider if pregnancy suspected

Question 33

Desogestrel / ethinyl estradiol MOA

Answer 33

Inhibit ovulation by suppressing gonadotropins , follicle stimulating hormone (FSH) and luteinizing hormone (LH).

Question 34

Desogestrel / ethinyl estradiol indications

Answer 34

Prevention of pregnancy in women

Question 35

Desogestrel / ethinyl estradiol

Answer 35

Biphasic Oral Contraceptive

Question 36

Norethindrone / ethinyl estradiol MOA

Answer 36

Inhibit ovulation by suppressing gonadotropins , follicle stimulating hormone (FSH) and luteinizing hormone (LH).

Question 37

Norethindrone / ethinyl estradiol indications

Answer 37

Prevention of pregnancy in women | Treatment of moderate acne vulgaris in women ≥ 15 years of age

Question 38

Norethindrone / ethinyl estradiol

Answer 38

Triphasic Oral Contraceptive

Question 39

Norethindrone MOA

Answer 39

***Suppresses ovulation in approximately 50% of users

Question 40

Norethindrone indications

Answer 40

Prevention of pregnancy in women

Question 41

Norethindrone adverse effects

Answer 41

Breakthrough bleeding, nausea

Question 42

Norethindrone

Answer 42

Progestin-Only Oral Contraceptives

Question 43

Norethindrone counseling

Answer 43

Effectiveness may be dramatically reduced when taken > 3 hours late Appropriate action if one or more progestin-only pills are missed

Question 44

Raloxifene MOA

Answer 44

Inhibits bone resorption | Reduces biochemical markers of bone turnover

Question 45

Raloxifene indications

Answer 45

Prevention and treatment of postmenopausal osteoporosis | Risk reduction of invasive breast cancer in

Question 46

Raloxifene

Answer 46

Selective Estrogen Receptor Modulator (SERMs)

Question 47

Raloxifene adverse effects

Answer 47

Hot flashes, nausea

Question 48

Raloxifene key facts

Answer 48

Avoid in patients with history of thromboembolic disorders

Question 49

Raloxifene counseling

Answer 49

Discontinue at least 72 hours prior to and during prolonged immobilization to prevent clot formations Avoid prolonged restrictions of movement during travel